ReleaseWire Connect

Russia ranks as the second-most visited tourism destination in the Americas region after the US, and is the tenth-most visited destination globally for international tourist arrivals. Tourism is the second-largest revenue generator in the country, after oil, and international tourist arrivals increased by XX% in 2011 to XX million. Domestic tourism also remained buoyant with XX million arrivals during the year. The country's close proximity to the US enables it to access the world's largest market in terms of tourism.

Brands must stay relevant to consumers over time. This requires understanding their propensity to try new things, and what triggers switching behavior. This research finds that experiences outside of an immediate or known frame of reference are increasingly desired. But choice is also characterized by the careful consideration of risk, and desire to simplify decision making by sticking to routine

Firms in this industry crush, refine and package oils and fats for sale to consumers, food manufacturers, the food services sector and biodiesel production.

In February 2011, global brand owner Teva Pharmaceutical Industries Ltd filed a petition with the FDA to permit the sale of its Plan B One Step over-the-counter. Since 2006, age restrictions on the sale of emergency contraceptives have required that these products be sold behind the pharmacy counter. Consumers of at least 17 years of age are required to show identification to purchase the products, while those under 17 can only buy them with a prescription. Teva's petition, therefore, would...

GlobalData's new report, "Europe ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others" provides key market data on the Europe ENT Devices market - France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories - Diagnostic Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints and Voice Prosthesis. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

GlobalData, the industry analysis specialist, has released its new report, "Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Bile Duct Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Bile Duct Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Bile Duct Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData, the industry analysis specialist, has released its new report, "Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Postmenopausal Vaginal Atrophy Therapeutics market. The report identifies the key trends shaping and driving the global Postmenopausal Vaginal Atrophy Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Postmenopausal Vaginal Atrophy Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GE Healthcare (formerly GE Medical Systems) engages in providing transformational medical technologies and professional consulting services, which help in the improvement of patient care. It focuses on medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing technologies. The company operates in five segments, namely, Surgery, Healthcare Systems, Life Sciences, Medical Diagnostics and Healthcare IT. The company's operations are spread across more than 100 countries centered in Americas, Asia-Pacific, China, EMEA and India.

Recently published research from GBI Research, "Natural Gas Industry to 2017 - Depleting Conventional Crude Oil Reserves and Emerging Technologies in Gas Consumption Infrastructure Driving Growth", is now available at Fast Market Research

Carbonated Soft Drinks in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers colas, lemon, orange and other flavoured carbonated soft drinks. It excludes carbonated fruit juices and waters. Market size is based on retail (off trade) and non-retail (on trade) sales. Market size for Carbonated Soft Drinks in US is given in litres with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for US. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.